The Washington State Liquor and Cannabis Board (WSLCB) is the primary adult use cannabis regulatory authority in the State of Washington. The executive agency, which also regulates alcohol, tobacco, and vapor products in Washington state, is overseen by a three member board appointed by the Governor to six-year terms. The Board holds regular public meetings and work sessions with stakeholders, makes policy and budget decisions, and adjudicates contested license applications and enforcement actions on licensees. Board members are also responsible for hiring the agency's Director, who manages day-to-day operations.
Washington State Liquor and Cannabis Board
(WSLCB)
Public
- WSLCB - Alcohol Advisory Council
- WSLCB - Board Caucus
- WSLCB - Board Meeting
- WSLCB - Cannabis Advisory Council
- WSLCB - COVID - Incident Command
- WSLCB - COVID - Legal/Policy/Rules Meeting
- WSLCB - Deliberative Dialogue
- WSLCB - Engagement
- WSLCB - Engagement - BIPOC
- WSLCB - Executive Management Team
- WSLCB - Focus Group
- WSLCB - Integrator Work Session
- WSLCB - Internal
- WSLCB - Listen and Learn Forum
- WSLCB - Special Board Caucus
- WSLCB - Special Board Meeting
- WSLCB - Traceability Advisory Committee
- WSLCB - Tribal Advisory Council
- WSLCB - Webinar
- WSLCB - Work Group - Cannabis Penalties
- WSLCB - Work Group - Cannabis Potency Tax
- WSLCB - Work Group - Healthy Youth Survey
- WSLCB - Work Group - Traceability 2.0
- WSLCB - Work Group - True Party of Interest
- WSLCB - Work Group - Voluntary Compliance Program
- WSLCB - World Cafe
Structural Relationships
-
Washington State Office of the Governor
(WA Governor) -
Washington State Liquor and Cannabis Board
(WSLCB) -
Washington State Task Force on Marijuana OdorInactive
(WA Task Force on Marijuana Odor) -
WSLCB Cannabinoid Science Work GroupInactive
(WSLCB - Work Group - Cannabinoid Science) -
WSLCB Quality Control Standards Work Group
(WSLCB - Work Group - QC Standards)
Information Set
-
WSLCB - Active Rulemaking Projects
[ InfoSet ]
- WSLCB - Employee Stock Ownership Plans - Rulemaking Project (October 9, 2024) [ InfoSet ]
- WSLCB - Identification Reform - Rulemaking Project (October 9, 2024) [ InfoSet ]
- WSLCB - Lab Authority Transfer - Rulemaking Project (July 17, 2024) [ InfoSet ]
- WSLCB - Minors on Wholesale Licensed Premises - Rulemaking Project (February 28, 2024) [ InfoSet ]
- WSLCB - Product Samples - Rulemaking Project (March 1, 2023) [ InfoSet ]
- WSLCB - SB 5080 Implementation - Rulemaking Project (November 8, 2023) [ InfoSet ]
- WSLCB - SB 5367 Implementation - Rulemaking Project (June 21, 2023) [ InfoSet ]
- WSLCB - SB 5376 Implementation - Rulemaking Project (May 22, 2024) [ InfoSet ]
-
WSLCB - Active Rulemaking Petitions
[ InfoSet ]
- WSLCB - Batch Tracking - Rulemaking Petition (August 29, 2023) [ InfoSet ]
- WSLCB - Biometric Identification - Rulemaking Petition (May 17, 2023) [ InfoSet ]
- WSLCB - Captive Insurance Companies - Rulemaking Petition (October 31, 2024) [ InfoSet ]
- WSLCB - COA Expiration Dates - Rulemaking Petition (October 30, 2023) [ InfoSet ]
- WSLCB - Employee Stock Ownership Plans - Rulemaking Petition (Mar 26, 2024) [ InfoSet ]
- WSLCB - Harvest or Processing Date - Rulemaking Petition (January 26, 2024) [ InfoSet ]
- WSLCB - Heavy Metals Testing - Rulemaking Petition (Dec 8, 2023) [ InfoSet ]
- WSLCB - Payment Flexibility - Rulemaking Petition (October 14, 2024) [ InfoSet ]
- WSLCB - Social Equity License Mobility - Rulemaking Petition (May 17, 2024) [ InfoSet ]
- WSLCB - Social Equity License Mobility - Rulemaking Petition (June 17, 2024) [ InfoSet ]
- WSLCB - Traceability Platform - Rulemaking Petition (October 2, 2024) [ InfoSet ]
- WSLCB - Transporter Fulfillment Hub - Rulemaking Petition (July 16, 2024) [ InfoSet ]
Observations
WSLCB - Board Meeting
(May 30, 2018) - Summary
The Board voted to adopt final rules for retail license forfeiture, hosted a public hearing on 2017 cannabis legislation implementation, and heard from several individuals during public comment.
WSLCB - Board Caucus
(May 29, 2018) - Summary
The Board heard positive feedback on changes to cannabis sampling guidelines before discussing volume discounts and cannabis economic forecasting.
WSLCB - Traceability Advisory Committee
(May 22, 2018) - Summary
An Independent Verification and Validation (IV&V) Project by Gartner Consulting was presented to the Committee and an executive from MJ Freeway defended the company's software development process.
WSLCB - Board Caucus
(May 22, 2018) - Summary
The Board discussed their representation at a federal law enforcement meeting and Regulators Roundtable, then discussed minority participation in the cannabis industry.
WSLCB - Board Meeting
(May 16, 2018) - Summary
A former Board Member responded to the Board's denial of his petition for rulemaking, licensees spoke on the absence of equity efforts by WSLCB, and the Board hosted a public hearing on the supplemental CR-102 for Marijuana License Forfeiture Rules.
WSLCB - Board Caucus
(May 15, 2018) - Summary
The Board weighed a petition to allow cannabis 'white labeling,' staff discussed cannabis tax collection and enforcement, and equity issues were raised again.
WSLCB - Traceability Advisory Committee
(May 11, 2018) - Summary
Members heard about data sources used to generate retail sales figures, future plans for sourcing those numbers, and the WSLCB's absence of plans to address data integrity issues.
WSLCB - Cannabis Advisory Council
(May 9, 2018) - Summary
The advisory council heard and commented on staff updates covering licensing, rulemaking, and legislative activity by the agency.
WSLCB - Executive Management Team
(May 2, 2018) - Summary
A legislative discussion was followed by a talk about increased collaboration with law enforcement against the illicit cannabis market before the Board considered speculation on oversupply of legal cannabis.
WSLCB - Board Meeting
(May 2, 2018) - Summary
The Board voted to adopt changes to packaging and labeling rules as well as an interim policy for licensees to expedite implementation of the new rules and public comment drew remarks on WSLCB's lack of consideration for medical cannabis patients and consumer over-reliance on cannabis potency numbers.